Lavipharm (FRA:BXA0) Beginning Cash Position : €8.44 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Lavipharm Beginning Cash Position?

Lavipharm's Beginning Cash Position for the quarter that ended in Jun. 2024 was €8.44 Mil.

Lavipharm's quarterly Beginning Cash Position declined from Jun. 2023 (€18.24 Mil) to Dec. 2023 (€14.41 Mil) and declined from Dec. 2023 (€14.41 Mil) to Jun. 2024 (€8.44 Mil).

Lavipharm's annual Beginning Cash Position declined from Dec. 2021 (€1.93 Mil) to Dec. 2022 (€1.64 Mil) but then increased from Dec. 2022 (€1.64 Mil) to Dec. 2023 (€18.24 Mil).

Lavipharm Beginning Cash Position Historical Data

The historical data trend for Lavipharm's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Beginning Cash Position Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

1.84

1.73

1.93

1.64

18.24

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Beginning Cash Position	Get a 7-Day Free Trial						1.64	2.74	18.24	14.41	8.44

Lavipharm Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Lavipharm Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Lavipharm's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

LAVI:Greece

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines